Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky M Avery

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|January 30, 2014
Euodenine A: a small-molecule agonist of human TLR4Juliette E Neve, Hasanthi P Wijesekera, Sandra Duffy, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|August 26, 2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious AntimalarialsBenoît Laleu, Yuichiro Akao, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansNicholas A Malmquist, Sandeep Sundriyal, Joachim Caron, et al.
Journal of Medicinal Chemistry|March 24, 2021
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazinesDaniel L Priebbenow, Mitch Mathiew, Da-Hua Shi, et al.
Mbio|May 8, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activityRebecca C S Edgar, Tess R Malcolm, Ghizal Siddiqui, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|January 30, 2014
Euodenine A: a small-molecule agonist of human TLR4Juliette E Neve, Hasanthi P Wijesekera, Sandra Duffy, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Journal of Medicinal Chemistry|August 26, 2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious AntimalarialsBenoît Laleu, Yuichiro Akao, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansNicholas A Malmquist, Sandeep Sundriyal, Joachim Caron, et al.
Journal of Medicinal Chemistry|March 24, 2021
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazinesDaniel L Priebbenow, Mitch Mathiew, Da-Hua Shi, et al.
Mbio|May 8, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activityRebecca C S Edgar, Tess R Malcolm, Ghizal Siddiqui, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Pageof 22